the objective of this study was to determine both the pharmacokinetic parameters and the bioavailability of a newly developed trimethoprim/sulfamethoxazole preparation ( cotrimoxazole , kepinol forte , 160 mg of trimethoprim/800 mg of sulfamethoxazole ) in comparison with a reference preparation customary in trade and registered according to the amg 1976 , after single oral administration .
C0041044
cotrimoxazole
C0038689
sulfamethoxazole